4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 5 | 28 | -18 | 20,204 | 239 |
| Gross Profit | 5 | 28 | -18 | 20,204 | 239 |
| Operating Expenses | 42,461 | 38,164 | 36,633 | 34,178 | 32,375 |
| Operating Income | -42,456 | -38,136 | -36,651 | -13,974 | -32,136 |
| Other Income | 7,503 | 5,735 | 4,368 | 3,718 | 2,520 |
| Pre-tax Income | -34,953 | -32,401 | -32,283 | -10,256 | -29,616 |
| Net Income Continuous | -34,953 | -32,401 | -32,283 | -10,256 | -29,616 |
| Net Income | $-34,953 | $-32,401 | $-32,283 | $-10,256 | $-29,616 |
| EPS Basic Total Ops | -0.63 | -0.66 | -0.69 | -0.24 | -0.77 |
| EPS Basic Continuous Ops | -0.63 | -0.66 | -0.69 | -0.24 | -0.77 |
| EPS Diluted Total Ops | -0.63 | -0.66 | -0.69 | -0.24 | -0.77 |
| EPS Diluted Continuous Ops | -0.63 | -0.66 | -0.69 | -0.24 | -0.77 |
| EPS Diluted Before Non-Recurring Items | -0.63 | -0.66 | -0.77 | N/A | N/A |
| EBITDA(a) | $-43,597 | $-37,720 | $-36,028 | $-13,130 | $-31,277 |